Latest Breaking News On - Nikang therapeutics - Page 1 : comparemela.com

Artios Pharma Bolsters Board of Directors with Appointment of Chris Liu, PhD

CAMBRIDGE, United Kingdom and NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) Artios Pharma Limited (“Artios”), clinical-stage biotech company led .

United kingdomCity ofNiall martinTim mccarthyChris liuMerck kgaArix bioscienceSenior research analystCancer research united kingdomInstitute of cancer researchArtios pharma limitedCrick instituteMaster of business administrationBusiness development at genscriptBiotech opportunities ltdNetherlands cancer institute

Artios Pharma Bolsters Board of Directors with Appointment

Artios Strengthens Board of Directors with Appointment of RTW Investments’ Chris Liu, Ph.D..

City ofUnited kingdomChris liuNiall martinTim mccarthyArtios pharma limitedCrick instituteMaster of business administrationBusiness development at genscriptMerck kgaArix bioscienceCancer research united kingdomSenior research analystInstitute of cancer researchArtios pharma ltdMerck kgaa

Adjuvant Pembrolizumab Significantly Prolongs OS vs Placebo in ccRCC

Treatment with adjuvant pembrolizumab significantly improved overall survival vs placebo in patients with clear cell renal cell carcinoma.

United statesDana farber cancer instituteBristol myers squibbNancy kohlbergToni choueiriRoche genentechCalithera biosciencesSanofi aventisMichaelj hennessy associatesGilead sciencesInfinity pharmaceuticalsLank centerKidney cancer programMedicine at harvard medical schoolFoundation medicineNavinata health

NiKang Therapeutics Enters into Clinical Trial Collaboration and Supply Agreement to Evaluate NKT2152 in Combination with Standard-of-Care in First-Line Advanced Hepatocellular Carcinoma

NiKang Therapeutics Enters into Clinical Trial Collaboration and Supply Agreement to Evaluate NKT2152 in Combination with Standard-of-Care in First-Line Advanced Hepatocellular Carcinoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kelsey chenZhenhai gaoNikang therapeutics incRoche ltdKang therapeuticsRenal cell carcinomaOperating officerNikang therapeutics

HBM Healthcare Investments publishes Half-Year Report as at 30 September 2023 with key figures for the second quarter of the 2023/2024 financial year

HBM Healthcare Investments publishes Half-Year Report as at 30 September 2023 with key figures for the second quarter of the 2023/2024 financial year
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Arrivent biopharmaSwixx biopharmaFangzhou jiankeWorld health care indexChina merchants groupBristol myers squibbAdarx pharmaceuticalsNasdaq biotechnology indexHealth care indexUpstream bioOdyssey therapeuticsCathay biotechMineralys therapeuticsChina merchantsNikang therapeuticsDren bio